晶門半導體(02878.HK):葉楠獲委任為非執行董事
格隆匯6月10日丨晶門半導體(02878.HK)發佈公吿,李峻博士已因其他事務安排而辭任非執行董事及投資委員會成員,自2021年6月10日起生效。
監於李博士辭任,葉楠女士已獲委任為非執行董事,自2021年6月10日起生效。經考慮葉女士的財務知識及經驗,葉女士亦獲委任為審核委員會的成員,自同日起生效。
隨着李博士辭任投資委員會成員,以及葉女士獲委任為審核委員會成員,原本擔任審核委員會成員的非執行董事及薪酬委員會成員王輝先生由審核委員會調任至投資委員會,成為投資委員會的成員,自2021年6月10日起生效。王先生將繼續擔任公司薪酬委員會成員。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.